<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheng CW</submitter><funding>TUBITAK-BIDEB</funding><funding>Helen Hay Whitney</funding><funding>NIA NIH HHS</funding><funding>Howard Hughes Medical Institute</funding><funding>Ludwig</funding><funding>NIH</funding><funding>TUBITAK</funding><funding>American Federation of Aging Research</funding><funding>V Foundation</funding><funding>Pew-Stewart Trust</funding><funding>NIDDK NIH HHS</funding><funding>Fondation MIT</funding><funding>Kathy and Curt Marble Cancer Research Fund</funding><funding>Sidney Kimmel</funding><funding>NCI NIH HHS</funding><funding>MIT Ludwig Center for Molecular Oncology Research</funding><funding>HHMI</funding><funding>Bridge</funding><funding>Klarman Cell Observatory</funding><funding>MIT Stem Cell Initiative</funding><pagination>1115-1131.e15</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6732196</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>178(5)</volume><pubmed_abstract>Little is known about how metabolites couple tissue-specific stem cell function with physiology. Here we show that, in the mammalian small intestine, the expression of Hmgcs2 (3-hydroxy-3-methylglutaryl-CoA synthetase 2), the gene encoding the rate-limiting enzyme in the production of ketone bodies, including beta-hydroxybutyrate (βOHB), distinguishes self-renewing Lgr5&lt;sup>+&lt;/sup> stem cells (ISCs) from differentiated cell types. Hmgcs2 loss depletes βOHB levels in Lgr5&lt;sup>+&lt;/sup> ISCs and skews their differentiation toward secretory cell fates, which can be rescued by exogenous βOHB and class I histone deacetylase (HDAC) inhibitor treatment. Mechanistically, βOHB acts by inhibiting HDACs to reinforce Notch signaling, instructing ISC self-renewal and lineage decisions. Notably, although a high-fat ketogenic diet elevates ISC function and post-injury regeneration through βOHB-mediated Notch signaling, a glucose-supplemented diet has the opposite effects. These findings reveal how control of βOHB-activated signaling in ISCs by diet helps to fine-tune stem cell adaptation in homeostasis and injury.</pubmed_abstract><journal>Cell</journal><pubmed_title>Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet.</pubmed_title><pmcid>PMC6732196</pmcid><funding_grant_id>R01CA034992</funding_grant_id><funding_grant_id>R01 CA211184</funding_grant_id><funding_grant_id>T32 CA009216</funding_grant_id><funding_grant_id>U54CA224068</funding_grant_id><funding_grant_id>U54 CA163109</funding_grant_id><funding_grant_id>K99 AG054760</funding_grant_id><funding_grant_id>R01CA211184</funding_grant_id><funding_grant_id>R01 CA034992</funding_grant_id><funding_grant_id>U54 CA224068</funding_grant_id><funding_grant_id>R00 AG045144</funding_grant_id><funding_grant_id>R00 AG054760</funding_grant_id><funding_grant_id>U54-CA163109</funding_grant_id><funding_grant_id>P30 DK043351</funding_grant_id><funding_grant_id>K99 DK123407</funding_grant_id><funding_grant_id>R01 CA207236</funding_grant_id><funding_grant_id>2214-A</funding_grant_id><funding_grant_id>2219</funding_grant_id><pubmed_authors>Whary MT</pubmed_authors><pubmed_authors>Boyer LA</pubmed_authors><pubmed_authors>Mino-Kenudson M</pubmed_authors><pubmed_authors>Fox JG</pubmed_authors><pubmed_authors>Mihaylova MM</pubmed_authors><pubmed_authors>Bauer-Rowe KE</pubmed_authors><pubmed_authors>Piwnica-Worms H</pubmed_authors><pubmed_authors>Gunduz N</pubmed_authors><pubmed_authors>Ulutas MS</pubmed_authors><pubmed_authors>Gaynor LT</pubmed_authors><pubmed_authors>Rai K</pubmed_authors><pubmed_authors>Yilmaz OH</pubmed_authors><pubmed_authors>Eng G</pubmed_authors><pubmed_authors>Calibasi-Kocal G</pubmed_authors><pubmed_authors>Mylonas C</pubmed_authors><pubmed_authors>Imada S</pubmed_authors><pubmed_authors>Butty VL</pubmed_authors><pubmed_authors>Biton M</pubmed_authors><pubmed_authors>Rickelt S</pubmed_authors><pubmed_authors>Tripathi S</pubmed_authors><pubmed_authors>Levine SS</pubmed_authors><pubmed_authors>Hynes RO</pubmed_authors><pubmed_authors>Deshpande V</pubmed_authors><pubmed_authors>Basbinar Y</pubmed_authors><pubmed_authors>Regev A</pubmed_authors><pubmed_authors>Cheng CW</pubmed_authors><pubmed_authors>Terranova C</pubmed_authors><pubmed_authors>Moreno-Serrano M</pubmed_authors><pubmed_authors>Haber AL</pubmed_authors><pubmed_authors>Iqbal AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet.</name><description>Little is known about how metabolites couple tissue-specific stem cell function with physiology. Here we show that, in the mammalian small intestine, the expression of Hmgcs2 (3-hydroxy-3-methylglutaryl-CoA synthetase 2), the gene encoding the rate-limiting enzyme in the production of ketone bodies, including beta-hydroxybutyrate (βOHB), distinguishes self-renewing Lgr5&lt;sup>+&lt;/sup> stem cells (ISCs) from differentiated cell types. Hmgcs2 loss depletes βOHB levels in Lgr5&lt;sup>+&lt;/sup> ISCs and skews their differentiation toward secretory cell fates, which can be rescued by exogenous βOHB and class I histone deacetylase (HDAC) inhibitor treatment. Mechanistically, βOHB acts by inhibiting HDACs to reinforce Notch signaling, instructing ISC self-renewal and lineage decisions. Notably, although a high-fat ketogenic diet elevates ISC function and post-injury regeneration through βOHB-mediated Notch signaling, a glucose-supplemented diet has the opposite effects. These findings reveal how control of βOHB-activated signaling in ISCs by diet helps to fine-tune stem cell adaptation in homeostasis and injury.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Aug</publication><modification>2024-11-12T13:27:25.128Z</modification><creation>2020-08-24T07:07:05Z</creation></dates><accession>S-EPMC6732196</accession><cross_references><pubmed>31442404</pubmed><doi>10.1016/j.cell.2019.07.048</doi></cross_references></HashMap>